Login
$OLMA
$7.36 -$0.20 (2.65%) Live

Company Executives

Officer Age In this role 2025 pay Source
Sean Bohen Also a director
President, Chief Executive Officer and Director
59 Not stated $3,178,990
Jason O'Byrne
CHIEF FINANCIAL OFFICER
Title from the Form 4 dated Sep 1, 2026
Not stated Not stated Not reported
Shawnte M. Mitchell
Chief Legal Officer and Corporate Secretary
48 Since 2025
1 year
$2,050,750
David C. Myles
Chief Scientific Officer
64 Since 2026
this year
Not reported
Naseem Zojwalla
Chief Medical Officer
53 Since 2022
4 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 29, 2026 · updated by the 8-K of Oct 15, 2026

Directors
10
serving now
Independent
0 of 1
stated in the proxy; 9 not stated
Average tenure
7.1 years
from year joined
CEO also chairs the board
No
Ian Clark
Director Age On board Independent Committees Other public boards 2025 pay Source
Ian Clark
65 2020
6 years
Not stated None stated BioMarin Pharmaceutical Inc. $145,688
Sean Bohen
59 2020
6 years
Not independent None stated AltruBio, Inc. Paid as CEO
Scott Garland
57 2023
3 years
Not stated None stated ALX Oncology $119,387
Yi Larson
46 2021
5 years
Not stated None stated Expedition Therapeutics Inc. $125,906
Andrew Rappaport
68 2013
13 years
Not stated
Audit Committee
None stated $121,438
Cynthia Butitta
71 2020
6 years
Not stated
Audit Committee · Chair
Autolus Therapeutics plc $126,841
Cyrus L. Harmon
55 2006
20 years
Not stated None stated None stated Not stated
Sandra Horning
77 2020
6 years
Not stated None stated Moderna, Inc. $118,188
Prakash Raman
56 2026
this year
Not stated
Compensation Committee Science and Technology Committee
Black Diamond Therapeutics, Inc. Not stated
Graham Walmsley
39 2020
6 years
Not stated
Audit Committee
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support